Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 85.82
-2.82 (-3.18%)
Jun 1, 2026, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 7.55 billion as of June 1, 2026. Its market cap has decreased by -31.86% in one year.
Market Cap
7.55B
Enterprise Value
6.50B
Revenue
427.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.82
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 7.55B, an increase of 71.15%. That is a compound annual growth rate of 8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 7.79B | -45.84% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.32B |
| Jiangxi Fushine Pharmaceutical | 8.24B |
| Aurisco Pharmaceutical | 8.00B |
| Bio-Thera Solutions | 7.94B |
| GemPharmatech | 7.93B |
| Youcare Pharmaceutical Group | 7.92B |
| Zhejiang Ausun Pharmaceutical | 7.85B |
| Shanghai Medicilon | 7.85B |